- Home
- IHS vs ANIP Comparison
IHS vs ANIP Comparison
Compare IHS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHS
- ANIP
- Stock Information
- Founded
- IHS 2001
- ANIP 2001
- Country
- IHS United Kingdom
- ANIP United States
- Employees
- IHS N/A
- ANIP N/A
- Industry
- IHS Telecommunications Equipment
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- IHS Telecommunications
- ANIP Health Care
- Exchange
- IHS Nasdaq
- ANIP Nasdaq
- Market Cap
- IHS 1.1B
- ANIP 1.2B
- IPO Year
- IHS 2021
- ANIP N/A
- Fundamental
- Price
- IHS $4.94
- ANIP $69.21
- Analyst Decision
- IHS Strong Buy
- ANIP Strong Buy
- Analyst Count
- IHS 5
- ANIP 8
- Target Price
- IHS $7.60
- ANIP $79.75
- AVG Volume (30 Days)
- IHS 722.6K
- ANIP 423.7K
- Earning Date
- IHS 05-13-2025
- ANIP 05-09-2025
- Dividend Yield
- IHS N/A
- ANIP N/A
- EPS Growth
- IHS N/A
- ANIP N/A
- EPS
- IHS N/A
- ANIP N/A
- Revenue
- IHS $1,711,225,000.00
- ANIP $614,376,000.00
- Revenue This Year
- IHS $0.40
- ANIP $27.62
- Revenue Next Year
- IHS $5.94
- ANIP $7.71
- P/E Ratio
- IHS N/A
- ANIP N/A
- Revenue Growth
- IHS N/A
- ANIP 26.20
- 52 Week Low
- IHS $2.44
- ANIP $52.50
- 52 Week High
- IHS $5.75
- ANIP $70.18
- Technical
- Relative Strength Index (RSI)
- IHS 57.15
- ANIP 60.35
- Support Level
- IHS $4.21
- ANIP $61.43
- Resistance Level
- IHS $4.69
- ANIP $68.82
- Average True Range (ATR)
- IHS 0.27
- ANIP 3.38
- MACD
- IHS -0.03
- ANIP -0.00
- Stochastic Oscillator
- IHS 66.10
- ANIP 85.97
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.